Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 2001, p. 1585-1588, Vol. 45, No. 5
The Clinical Microbiology Institute,
Wilsonville, Oregon 97070
Received 14 August 2000/Returned for modification 18 December
2000/Accepted 23 February 2001
A challenge set of 143 non-
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.5.1585-1588.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of
-Lactamase-Negative,
Ampicillin-Resistant Strains of Haemophilus influenzae with
Four Methods and Eight Media
-lactamase-producing strains of
Haemophilus influenzae was tested for ampicillin
susceptibility on two broth media and six agar media, using broth
microdilution, agar dilution, disk diffusion, and E-test procedures.
When
-lactamase-negative, ampicillin-resistant (BLNAR) strains were
defined as those for which the ampicillin MIC was
4.0 µg/ml, 5 to
44% of our selected strains were BLNAR depending on the medium and/or
test method used. If nonsusceptible strains for which ampicillin MICs
were intermediate were included in the BLNAR category, 32 to 50% of our isolates would be considered BLNAR. These data emphasize the need
for a standardized testing procedure and a universal definition of
BLNAR strains before the clinical relevance of such strains can be
evaluated. NCCLS dilution tests with haemophilus test medium broth or
agar are preferred for testing ampicillin against H. influenzae.
*
Corresponding author. Mailing address: The Clinical
Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR
97070-9601. Phone: (503) 682-3232. Fax: (503) 682-4548. E-mail:
cmi{at}hevanet.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»